Record performance of its GLP-1 drugs sent shares in Eli Lilly soaring almost 4% after its earnings call on Thursday.
Eli Lilly shares rise as Q3 revenue jumps 54% to $17.6 billion, earnings top estimates, and analysts lift price targets on ...
Fintel reports that on October 31, 2025, Cantor Fitzgerald maintained coverage of Eli Lilly and (NYSE:LLY) with a Overweight ...
U.S. pharmaceutical company Eli Lilly (LLY) says that the weight-loss pill it is developing should be a candidate for ...
AstraZeneca, Eli Lilly and Merck committed $120 million to develop an advanced pharmaceutical manufacturing training center in Central Virginia.
Eli Lilly, Zyrtec and Astellas Pharma recently invested in celeb partnerships to raise awareness about conditions.
Pfizer has filed a lawsuit against Metsera and Novo Nordisk, saying Metsera breached its merger agreement obligations.
The AI chip darling already has the most cutting-edge products and the best customers. The next thing to do is to find more ...
The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker.
Gary Walter Davaney, a man whose kindness, humor, energy, and unforgettable spirit touched countless lives, passed away after a courageous 21-year battle with cancer.
Alnylam Pharmaceuticals, Inc. is rated Hold due to high expectations, competitive threats, and revenue expansion. Learn more ...
Pfizer has decided to sue Metsera and Novo over $8.5B bid, citing antitrust risks and asserting regulatory advantage.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results